Exenatide
3 NDCs across 2 manufacturers|1 Generic,2 Brand
Exenatide is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $16 million on Exenatide across 12,000 claims for 3,043 beneficiaries.
Exenatide is available as 3 NDCs from 2 manufacturers (1 generic, 2 brand), with NADAC prices from $300.17 to $681.26 per ML — the most expensive product costs about 2.3× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
1G / 2B
Manufacturers
2
competing in market
Price Spread
$300.17 – $681.26
per ML
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing EXENATIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BYETTA 5 MCG DOSE PEN INJ | $681.2626 per ML | — |
BYETTA 10 MCG DOSE PEN INJ | $340.1014 per ML | — |
EXENATIDE 10 MCG DOSE PEN INJ | $300.1675 per ML | — |
Frequently Asked Questions
What is Exenatide used to treat?
Exenatide is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Exenatide?
In 2024, Medicare Part D spent $16 million on Exenatide across 12,000 claims for 3,043 beneficiaries.
How many Exenatide products are on the market?
The Exenatide drug market contains 3 NDCs from 2 manufacturers — 1 generic and 2 brand products.
What is the price range for Exenatide?
NADAC reference prices for Exenatide range from $300.1675 to $681.2626 per ML — the most expensive product costs about 2.3× the cheapest.
Is generic Exenatide cheaper than brand?
The average generic NADAC for Exenatide is $300.1675 per ML, versus $510.6820 for brand-labeled products — generic is about 41% cheaper on average.
Which manufacturers make Exenatide?
2 manufacturers list Exenatide in NADAC. Ranked by number of NDCs, the largest are AstraZeneca Pharmaceuticals LP (2), Amneal Pharmaceuticals LLC (1).